Tocilizumab Use in a Chronic Hemodialysis Patient for the Management of COVID-19-Associated Pneumonia and Acute Respiratory Distress Syndrome
Novel coronavirus disease 2019 (COVID-19) is a highly infectious, rapidly spreading viral disease. As of writing this article, there are over 4.4 million people affected by COVID-19, and unfortunately, 300,000 have succumbed to the infection. In this article, we address a particularly more susceptib...
Main Authors: | Sudeendra Gupta, Rakesh Madhyastha, Fadi Hamed, Maher Balkis, Wasim El Nekidy, Nizar Attallah |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2020-01-01
|
Series: | Case Reports in Nephrology |
Online Access: | http://dx.doi.org/10.1155/2020/8829309 |
Similar Items
-
Thrombotic events following tocilizumab therapy in critically ill COVID-19 patients: a Façade for prognostic markers
by: Bassam Atallah, et al.
Published: (2020-09-01) -
Treatment of the Patient with COVID-19 Pneumonia with Tocilizumab
by: Özgür GÜNAL, et al.
Published: (2020-06-01) -
Tocilizumab and steroid treatment in patients with COVID-19 pneumonia.
by: Malgorzata Mikulska, et al.
Published: (2020-01-01) -
Successful treatment of multidrug resistant Klebsiella pneumoniae using dual carbapenem regimen in immunocompromised patient
by: Wasim S. El Nekidy, et al.
Published: (2017-01-01) -
Early use of tocilizumab in respiratory failure associated with acute COVID -19 pneumonia in recipients with solid organ transplantation
by: Suresh J. Antony, et al.
Published: (2020-01-01)